Alan B. Lancz & Associates’s CVS Health CVS Stock Holding History

Alan B. Lancz & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,685	Closed	-$232K	–	130
2024 Q3	$232K	Hold	3,685	–	–	0.21%	118
2024 Q2	$218K	Buy	+3,685	New	+$231K	0.22%	115
2023 Q4	$307K	Hold	3,885	–	–	0.32%	90
2023 Q3	$271K	Sell	3,885 -500	-11%	-$35.4K	0.31%	100
2023 Q2	$303K	Hold	4,385	–	–	0.32%	97
2023 Q1	$326K	Hold	4,385	–	–	0.34%	91
2022 Q4	$394K	Hold	4,385	–	–	0.4%	80
2022 Q3	$418K	Hold	4,385	–	–	0.5%	58
2022 Q2	$420K	Sell	4,385 -451	-9%	-$44K	0.42%	68
2022 Q1	$489K	Hold	4,836	–	–	0.43%	70
2021 Q4	$499K	Buy	+4,836	New	+$447K	0.44%	66

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alan B. Lancz & Associates's CVS Position: Q4 2024 in Review

Alan B. Lancz & Associates sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,685 shares — an estimated $232K sold.

Alan B. Lancz & Associates first reported a position in CVS in Q4 2021 and held it in 11 quarters. The position peaked at $499K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Alan B. Lancz & Associates reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Alan B. Lancz & Associates sold 3,685 CVS Health shares in Q4 2024, an estimated $232K.
Alan B. Lancz & Associates first reported a position in CVS Health in Q4 2021 and held it in 11 quarters.
Alan B. Lancz & Associates's CVS Health position peaked at $499K in Q4 2021.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Alan B. Lancz & Associates's 13F filing for Q4 2024, filed 21 Jan 2025.